68220-022 : Sf Rowasa 4 g/60ml Rectal Suspension


NDC68220-022
Labeler: Alaven Pharmaceutical LLC
Product Type: Human Prescription Drug
Drug Name:  Sf Rowasa
Dosage Form: Rectal Suspension
Application #: NDA019618
Rev. Date: 


NDC Package Codes:

  • 68220-022-01: 1 BOTTLE, WITH APPLICATOR IN 1 CARTON (68220‑022‑01) > 60 ML IN 1 BOTTLE, WITH APPLICATOR (68220‑022‑60)
  • 68220-022-07: 7 BOTTLE, WITH APPLICATOR IN 1 CARTON (68220‑022‑07) > 60 ML IN 1 BOTTLE, WITH APPLICATOR (68220‑022‑60)
  • 68220-022-14: 14 BOTTLE, WITH APPLICATOR IN 1 CARTON (68220‑022‑14) > 60 ML IN 1 BOTTLE, WITH APPLICATOR (68220‑022‑60)
  • 68220-022-28: 28 BOTTLE, WITH APPLICATOR IN 1 CARTON (68220‑022‑28) > 60 ML IN 1 BOTTLE, WITH APPLICATOR (68220‑022‑60)

Active Ingredients:

  • Mesalamine

Dosage Strength:

  • 4 g/60mL

Pharmaceutical Classes:

  • Aminosalicylate [EPC]
  • Aminosalicylic Acids [Chemical/Ingredient]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 68220-022 QR Code

< Prev: 68210-8100Next: 68220-055 >

Related Discussions:

Will PENTASA (mesalamine) contradict diabetes medications
I am taking PENTASA (mesalamine) 500 mg tablets daily (6 tabs daily) and I also use azoran 5 mg two tabs daily. Will it ...
Cheap Purchase of Mesalamine Enemas
I am interested in self-employment. I have Ulcerative Colitis. I need this medication to stay alive. My doctor tells me ... 1 reply
Asacol (mesalamine) delayed-release tablet
mesalamine delayed-release tablet information...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.